Dacomitinib-induced purpuric drug eruptions associated with IQGAP1 upregulation in a patient with lung adenocarcinoma

J Dtsch Dermatol Ges. 2023 Jul;21(7):795-797. doi: 10.1111/ddg.15067. Epub 2023 May 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung*
  • Drug Eruptions* / diagnosis
  • Drug Eruptions* / etiology
  • Drug Eruptions* / pathology
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Mutation
  • Protein Kinase Inhibitors
  • Up-Regulation

Substances

  • dacomitinib
  • IQ motif containing GTPase activating protein 1
  • Protein Kinase Inhibitors